Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Metastatic potential is determined early in synovial sarcoma development and reflected by tumor molecular features.

Przybyl J, Sciot R, Wozniak A, Schöffski P, Vanspauwen V, Samson I, Siedlecki JA, Rutkowski P, Debiec-Rychter M.

Int J Biochem Cell Biol. 2014 Aug;53:505-13. doi: 10.1016/j.biocel.2014.05.006. Epub 2014 May 16.

PMID:
24842110
2.

Chromosome instability accounts for reverse metastatic outcomes of pediatric and adult synovial sarcomas.

Lagarde P, Przybyl J, Brulard C, Pérot G, Pierron G, Delattre O, Sciot R, Wozniak A, Schöffski P, Terrier P, Neuville A, Coindre JM, Italiano A, Orbach D, Debiec-Rychter M, Chibon F.

J Clin Oncol. 2013 Feb 10;31(5):608-15. doi: 10.1200/JCO.2012.46.0147. Epub 2013 Jan 14.

PMID:
23319690
3.

Synovial sarcoma. A Scandinavian Sarcoma Group project.

Skytting B.

Acta Orthop Scand Suppl. 2000 Apr;291:1-28.

PMID:
10862210
4.

Response to chemotherapy is not related to chromosome instability in synovial sarcoma.

Chakiba C, Lagarde P, Pissaloux D, Neuville A, Brulard C, Pérot G, Coindre JM, Terrier P, Ranchere-Vince D, Ferrari A, Collini P, Suurmeijer AJ, Blay JY, Terrisse SA, Piperno-Neumann S, Averous G, Bui B, Orbach D, Italiano A, Chibon F.

Ann Oncol. 2014 Nov;25(11):2267-71. doi: 10.1093/annonc/mdu362. Epub 2014 Jul 28.

5.

Clinical impact of molecular and cytogenetic findings in synovial sarcoma.

Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Akerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Dêbiec-Rychter M, Szadowska A, Brosjö O, Larsson O, Rydholm A, Mandahl N.

Genes Chromosomes Cancer. 2001 Aug;31(4):362-72.

PMID:
11433527
6.

Synovial sarcoma of the abdominal wall.

Fetsch JF, Meis JM.

Cancer. 1993 Jul 15;72(2):469-77.

PMID:
8391380
7.

Synovial sarcoma: identification of low and high risk groups.

Bergh P, Meis-Kindblom JM, Gherlinzoni F, Berlin O, Bacchini P, Bertoni F, Gunterberg B, Kindblom LG.

Cancer. 1999 Jun 15;85(12):2596-607.

PMID:
10375108
8.

Correlation between clinicopathological features and karyotype in spindle cell sarcomas. A report of 130 cases from the CHAMP study group.

Fletcher CD, Dal Cin P, de Wever I, Mandahl N, Mertens F, Mitelman F, Rosai J, Rydholm A, Sciot R, Tallini G, van den Berghe H, Vanni R, Willén H.

Am J Pathol. 1999 Jun;154(6):1841-7.

9.

Anaplastic sarcoma of the kidney: a clinicopathologic study of 20 cases of a new entity with polyphenotypic features.

Vujanić GM, Kelsey A, Perlman EJ, Sandstedt B, Beckwith JB.

Am J Surg Pathol. 2007 Oct;31(10):1459-68.

PMID:
17895746
10.

Low expression of p27(Kip1), a cyclin-dependent kinase inhibitor, is a marker of poor prognosis in synovial sarcoma.

Kawauchi S, Goto Y, Liu XP, Furuya T, Oga A, Oda Y, Tsuneyoshi M, Ihara K, Sasaki K.

Cancer. 2001 Mar 1;91(5):1005-12.

PMID:
11251953
11.

Prognostic factors in synovial sarcoma.

Rööser B, Willén H, Hugoson A, Rydholm A.

Cancer. 1989 Jun 1;63(11):2182-5.

PMID:
2541885
12.

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O.

Cancer Res. 2002 Jan 1;62(1):135-40.

13.

Clinical effect of molecular methods in sarcoma diagnosis (GENSARC): a prospective, multicentre, observational study.

Italiano A, Di Mauro I, Rapp J, Pierron G, Auger N, Alberti L, Chibon F, Escande F, Voegeli AC, Ghnassia JP, Keslair F, Laé M, Ranchère-Vince D, Terrier P, Baffert S, Coindre JM, Pedeutour F.

Lancet Oncol. 2016 Apr;17(4):532-538. doi: 10.1016/S1470-2045(15)00583-5. Epub 2016 Mar 10.

PMID:
26970672
14.

Synovial sarcoma of the vulva and vagina: a clinicopathologic and molecular genetic study of 4 cases.

Sumathi VP, Fisher C, Williams A, Meis JM, Ganesan R, Kindblom LG, McCluggage WG.

Int J Gynecol Pathol. 2011 Jan;30(1):84-91. doi: 10.1097/PGP.0b013e3181f0c510.

PMID:
21131827
15.

Gene expression profiles relate to SS18/SSX fusion type in synovial sarcoma.

Fernebro J, Francis P, Edén P, Borg A, Panagopoulos I, Mertens F, Vallon-Christersson J, Akerman M, Rydholm A, Bauer HC, Mandahl N, Nilbert M.

Int J Cancer. 2006 Mar 1;118(5):1165-72.

16.

DNA ploidy and karyotype in recurrent and metastatic soft tissue sarcomas.

Van den Berg E, Molenaar WM, Hoekstra HJ, Kamps WA, de Jong B.

Mod Pathol. 1992 Sep;5(5):505-14.

PMID:
1344814
17.

Prognosis of T1 synovial sarcoma depends upon surgery by oncologic surgeons.

El Beaino M, Araujo DM, Gopalakrishnan V, Lazar AJ, Lin PP.

J Surg Oncol. 2016 Sep;114(4):490-4. doi: 10.1002/jso.24306. Epub 2016 May 24.

PMID:
27220538
18.

Clinical importance of genomic imbalances in synovial sarcoma evaluated by comparative genomic hybridization.

Skytting BT, Szymanska J, Aalto Y, Lushnikova T, Blomqvist C, Elomaa I, Larsson O, Knuutila S.

Cancer Genet Cytogenet. 1999 Nov;115(1):39-46.

PMID:
10565298
19.

Expression of MYCN in pediatric synovial sarcoma.

Somers GR, Zielenska M, Abdullah S, Sherman C, Chan S, Thorner PS.

Mod Pathol. 2007 Jul;20(7):734-41. Epub 2007 Apr 27.

20.

Minute synovial sarcomas of the hands and feet: a clinicopathologic study of 21 tumors less than 1 cm.

Michal M, Fanburg-Smith JC, Lasota J, Fetsch JF, Lichy J, Miettinen M.

Am J Surg Pathol. 2006 Jun;30(6):721-6.

PMID:
16723849

Supplemental Content

Support Center